19/12/2022
We're delighted to have assisted Shield Therapeutics plc with shareholder documentation for its incredibly successful - upsized twice and still oversubscribed! - US$18.5m fundraising by means of a placing and open offer of up to £3.9m. Congratulations to the company and its advisors Taylor Wessing and finnCap Group on this great achievement!
Other recent news
11/09/2026
Engineering the best outcome: B&C assists with £345m acquisition…
03/09/2026
B&C helps with the £404m acquisition of Picton Property Income b…
24/08/2026
B&C helps EnQuest's $833m acquisition and re-admission by way of…
14/08/2026